Another Benefit of Gout Treatment: CV Risk Reduction
Growing evidence suggests that a guideline-directed, treat-to-target strategy in patients with gout not only controls the disease but also reduces cardiovascular risks.
Source: medscape.com
Michael Garshick News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Michael Garshick. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Michael Garshick Today - Breaking & Trending Today
Evidence Builds to Support Colchicine in Treating ASCVD
Colchicine, a legacy drug that received a new indication in 2023 for cardiovascular disease, can treat arterial inflammation after a heart attack, a principal investigator of clinical trials said.
Source: medscape.com
Psoriasis: Why severe cases can raise the risk of heart disease
Researchers report that severe cases of psoriasis can affect a person's blood flow and subsequently increase their risk of cardiovascular disease
Source: medicalnewstoday.com
Psoriasis Drug May Have Some Cardiometabolic Benefits
Nonrandomized trial shows 5%-6% reduction in both visceral and subcutaneous fat, but no effect on aortic vascular inflammation.
Source: medscape.com
Apremilast's Effect on CVD Risk Markers Evaluated in Study
'There has been a keen interest in understanding how psoriasis therapies impact cardiovascular risk,' said Joel Gelfand, MD, who presented the findings at the American Academy of Dermatology meeting.
Source: medscape.com